APERTURE VENTURE PARTNERS IV, L.P. purchased 48.1% of their position (112K shares) of TREVI THERAPEUTICS, INC. on the open market
Open‑market purchase worth $1.12M — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 5/13/2019ACC: 0000899243-19-013254
10% Owner
Since May 2019
-1.71M
Net shares
Net seller
$1.12M
Total acquired
1
Open market trades
1B · 0S
3
Total transactions
344.96K acquired · 2.05M disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+232.96K
Price / share
—
Trade value
—
% of position
New position
5/9/2019
0.00→232.96K
Common Stock
Direct
Shares
+112K
Price / share
$10.00
Trade value
$1.12M
% of position
48.1%
5/9/2019
232.96K→344.96K
Total
Net shares
+344.96K
Net value
$1.12M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/9/2019 | C · Conversion | +232.96K | — | — | New position | 0.00 | 232.96K |
| Common Stock Direct | 5/9/2019 | P · Purchase | +112K | $10.00 | $1.12M | 48.1% | 232.96K | 344.96K |
| Total | +344.96K | $1.12M | ||||||
Derivative Transactions1
Series C Preferred Stock
Direct
Converts to
Common Stock
232.96K shares
Shares
−2.05M
Strike price
Held after
0.00
Exercisable
—
5/9/2019
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Series C Preferred Stock Direct | Common Stock232.96K shares | 5/9/2019 | C · Conversion | −2.05M | — | 0.00 |